Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial.
Faivre-Finn C, Snee M, Ashcroft L, Appel W, Barlesi F, Bhatnagar A, Bezjak A, Cardenal F, Fournel P, Harden S, Le Pechoux C, McMenemin R, Mohammed N, O'Brien M, Pantarotto J, Surmont V, Van Meerbeeck JP, Woll PJ, Lorigan P, Blackhall F; CONVERT Study Team.
Lancet Oncol. 2017 Aug;18(8):1116-1125. doi: 10.1016/S1470-2045(17)30318-2. Epub 2017 Jun 20.
Mapping of Lymph Node Metastasis From Esophagogastric Junction Tumors: A Prospective Nationwide Multicenter Study.
Kurokawa Y, Takeuchi H, Doki Y, Mine S, Terashima M, Yasuda T, Yoshida K, Daiko H, Sakuramoto S, Yoshikawa T, Kunisaki C, Seto Y, Tamura S, Shimokawa T, Sano T, Kitagawa Y.
Ann Surg. 2021 Jul 1;274(1):120-127. doi: 10.1097/SLA.0000000000003499.
Pattern of relapse following three-field lymphadenectomy of esophageal carcinoma and related factors predictive of recurrence.
Xu ZC, Su BA, Li JC, Cheng WF, Chen J.
Cancer Radiother. 2023 May;27(3):189-195. doi: 10.1016/j.canrad.2022.09.001. Epub 2023 Feb 6.
Esophageal squamous cell carcinoma metachronous to head and neck cancers.
Businello G, Fassan M, Degasperi S, Traverso G, Scarpa M, Angriman I, Kotsafti A, Castagliuolo I, Sbaraglia M, Bardini R, Scarpa M.
Pathol Res Pract. 2021 Mar;219:153346. doi: 10.1016/j.prp.2021.153346. Epub 2021 Jan 27.
Esophageal carcinoma: ex vivo evaluation with diffusion-tensor MR imaging and tractography at 7 T.
Yamada I, Hikishima K, Miyasaka N, Kawano T, Tokairin Y, Ito E, Kobayashi D, Eishi Y, Okano H.
Radiology. 2014 Jul;272(1):164-73. doi: 10.1148/radiol.14132170. Epub 2014 Mar 21.
Management of resectable esophageal and gastric (mixed adeno)neuroendocrine carcinoma: A nationwide cohort study.
van der Veen A, Seesing MFJ, Wijnhoven BPL, de Steur WO, van Berge Henegouwen MI, Rosman C, van Sandick JW, Mook S, Haj Mohammad N, Ruurda JP, Brosens LAA, van Hillegersberg R; (MA)NEC group.
Eur J Surg Oncol. 2018 Dec;44(12):1955-1962. doi: 10.1016/j.ejso.2018.07.058. Epub 2018 Aug 2.
Association between dietary behavior and esophageal squamous cell carcinoma in Yanting.
Zhao L, Liu CL, Song QK, Deng YM, Qu CX, Li J.
Asian Pac J Cancer Prev. 2014;15(20):8657-60. doi: 10.7314/apjcp.2014.15.20.8657.
Preoperative NLR and PLR in the middle or lower ESCC patients with radical operation.
He YF, Luo HQ, Wang W, Chen J, Yao YW, Yan Y, Wu SS, Hu XX, Ke LH, Niu JY, Li HM, Ji CS, Hu B.
Eur J Cancer Care (Engl). 2017 Mar;26(2). doi: 10.1111/ecc.12445. Epub 2016 Mar 7.
Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.
Salem ME, Puccini A, Xiu J, Raghavan D, Lenz HJ, Korn WM, Shields AF, Philip PA, Marshall JL, Goldberg RM.
Oncologist. 2018 Nov;23(11):1319-1327. doi: 10.1634/theoncologist.2018-0143. Epub 2018 Jun 4.
Postoperative lymphatic recurrence distribution and delineation of the radiation field in lower thoracic squamous cell esophageal carcinomas: a real-world study.
Du R, Fan S, Wang X, Hou X, Zeng C, Guo D, Tian R, Yang D, Jiang L, Dong X, Yu R, Yu H, Li D, Zhu S, Li J, Shi A.
Radiat Oncol. 2022 Mar 5;17(1):47. doi: 10.1186/s13014-022-01987-7.
